ClassID:

109145

C12N2310/14 - page 27 - CPC Classification

Classification description:

Structure or type of the nucleic acid; Type of nucleic acid interfering N.A.

Recent Application in this class:
#7801
20110053802
2011-03-03

CATEGORIZATION OF MICROBIAL COMMUNITIES

#7802
20110052677
2011-03-03

MODULATION OF SRPX2-MEDIATED ANGIOGENESIS

#7803
20110052669
2011-03-03

Methods for modulating de novo hepatic lipogenesis by modulating XBP-1 activity

#7804
20110052591
2011-03-03

Variants of Thyroid Stimulating Hormone Beta

#7805
20110052546
2011-03-03

Inhibition of SHIP to Enhance Stem Cell Harvest and Transplantation

#7806
20110047645
2011-02-24

Compositions and Methods of Using RNA Interference for Control of Nematodes

#7807
20110046206
2011-02-24

DOUBLE STRAND COMPOSITIONS COMPRISING DIFFERENTIALLY MODIFIED STRANDS FOR USE IN GENE MODULATION

#7808
20110046201
2011-02-24

METHODS AND COMPOSITIONS FOR SEAMLESS CLONING OF NUCLEIC ACID MOLECULES

#7809
20110046067
2011-02-24

COMPOSITIONS COMPRISING HUMAN EGFR-siRNA AND METHODS OF USE

#7810
20110045473
2011-02-24

LIVER SCREENING METHOD

#7811
20110045080
2011-02-24

Single-Walled Carbon Nanotube/Bioactive Substance Complexes and Methods Related Thereto

#7812
20110045002
2011-02-24

METHODS OF MODULATING IMMUNE RESPONSES BY MODULATING TIM-1, TIM-2 AND TIM-4 FUNCTION

#7813
20110045001
2011-02-24

Transfection results of non-viral gene delivery systems by influencing of the innate immune system

#7814
20110044931
2011-02-24

Multi-conjugate of siRNA and preparing method thereof

#7815
20110039915
2011-02-17

Immunostimulatory siRNA molecules

#7816
20110039914
2011-02-17

Modified RNAi polynucleotides and uses thereof

#7817
20110039912
2011-02-17

Therapeutic agent for neuroblastoma targeting ARID3b

#7818
20110039909
2011-02-17

METHODS AND MATERIALS FOR REDUCING GLI2 EXPRESSION

#7819
20110039785
2011-02-17

POLYPEPTIDE-NUCLEIC ACID CONJUGATES AND USES THEREOF

#7820
20110039734
2011-02-17

siRNA targeting connective tissue growth factor (CTGF)

#7821
20110038922
2011-02-17

COMPOUNDS FOR TREATING OR PREVENTING AMINE OXIDASE RELATED DISEASES OR DISORDERS

#7822
20110038920
2011-02-17

WOUND HEALING COMPOSITIONS AND TREATMENTS

#7823
20110038873
2011-02-17

Means and methods for treating or preventing brain tumors based on the nuclear receptor tailless (Tlx)

#7824
20110038871
2011-02-17

CCR2 INHIBITORS FOR TREATING CONDITIONS OF THE EYE

#7825
20110038853
2011-02-17

Use of Kif13A and AP-1 Inhibitors for Inhibiting Melanogenesis

#7826
20110038852
2011-02-17

ANTIVIRALS THAT TARGET TRANSPORTERS, CARRIERS, AND ION CHANNELS

#7827
20110038849
2011-02-17

INHIBITORY POLYNUCLEOTIDE COMPOSITIONS AND METHODS FOR TREATING CANCER

#7828
20110038792
2011-02-17

Induction of thyroid iodide-handling gene expression in human cancers

#7829
20110034677
2011-02-10

Recurrent gene fusions in prostate cancer

#7830
20110034537
2011-02-10

Compositions and methods for inhibiting expression of CD45 gene

#7831
20110034535
2011-02-10

Positive controls for expression modulating experiments

#7832
20110034534
2011-02-10

siRNA compounds and methods of use thereof

#7833
20110034349
2011-02-10

SiRNA targeting proto-oncogene MET

#7834
20110033860
2011-02-10

Method For Searching Target Base Sequence Of Rna Interference, Method For Designing Base Sequence Of Polynucleotide For Causing Rna Interference, Method For Producing Double-Stranded Polynucleotide, Method For Inhibiting Gene Expression, Base Sequence Processing Apparatus, Program For Running Base Sequence Processing Method On Computer, Recording Medium, And Base Sequence Processing System

#7835
20110033859
2011-02-10

Enhancement of influenza gene expression

#7836
20110033551
2011-02-10

Nucleic acid microspheres, production and delivery thereof

#7837
20110033547
2011-02-10

DEHYDRATED CHITOSAN NANOPARTICLES

#7838
20110033443
2011-02-10

Method for increasing bone mass

#7839
20110030075
2011-02-03

Methods and Compositions Capable of Causing Post-Transcriptional Silencing of Gene Expression in a Synergic Manner

#7840
20110030073
2011-02-03

THERAPEUTIC TARGETS AND MEDICAMENTS INVOLVING P230/GOLGIN-245

#7841
20110028536
2011-02-03

METHODS AND COMPOSITIONS FOR TOPOISOMERASE I MODULATED TUMOR SUPPRESSION

#7842
20110028534
2011-02-03

RNAi INHIBITION OF CTGF FOR TREATMENT OF OCULAR DISORDERS

#7843
20110028533
2011-02-03

NOVEL FER -LIKE PROTEIN, PHARMACEUTICAL COMPOSITIONS CONTAINING IT AND METHOD FOR ITS USE

#7844
20110028532
2011-02-03

Methods of treating eye diseases in diabetic patients

#7845
20110028531
2011-02-03

NOVEL SIRNA COMPOUNDS FOR INHIBITING RTP801

#7846
20110027883
2011-02-03

RNA interference mediating small RNA molecules

#7847
20110027882
2011-02-03

Methods and Compositions for Treating Neurological Disease

#7848
20110027297
2011-02-03

Methods Involving MS4A12 and Agents Targeting MS4A12 for Therapy, Diagnosis and Testing

#7849
20110027248
2011-02-03

Sugar Chain-Related Gene and Use Thereof

#7850
20110027239
2011-02-03

ADIPOSE-DERIVED STROMAL CELLS (ASC) AS DELIVERY TOOL FOR TREATMENT OF CANCER

#7851
20110027186
2011-02-03

TAZ/WWTR1 for diagnosis and treatment of cancer

#7852
20110021608
2011-01-27

Methods for nucleic acid transfer into cells

#7853
20110021605
2011-01-27

MEANS AND METHODS FOR THE SPECIFIC INHIBITION OF GENES IN CELLS AND TISSUE OF THE CNS AND/OR EYE

#7854
20110021604
2011-01-27

Methods and compositions for the specific inhibition of KRAS by asymmetric double-stranded RNA

#7855
20110021600
2011-01-27

NOVEL NUCLEIC ACID

#7856
20110021382
2011-01-27

siRNA targeting amyloid beta (A4) precursor protein (APP)

#7857
20110020368
2011-01-27

TREATING CANCER BY DOWN-REGULATING FRIZZLED-4 AND/OR FRIZZLED-1

#7858
20110020364
2011-01-27

Methods and compositions involving PBEF inhibitors for lung inflammation conditions and diseases

#7859
20110020300
2011-01-27

COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF GLUCOCORTICOID RECEPTOR (GCR) GENES

#7860
20110020234
2011-01-27

RNA interference mediating small RNA molecules

#7861
20110015250
2011-01-20

COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF Eg5 GENE

#7862
20110015249
2011-01-20

METHODS AND COMPOSITIONS FOR TREATMENT OF CANCER AND OTHER ANGIOGENESIS-RELATED DISEASES

#7863
20110015123
2011-01-20

Modulation of GLUT4 Gene Promoter activity BY AHNAK

#7864
20110015093
2011-01-20

High throughput methods for functionally determining RNA interference efficiency

#7865
20110014275
2011-01-20

Compositions and methods for inhibiting adipogenesis by inhibition of constitutive coactivator of ppargamma

#7866
20110014202
2011-01-20

Methods for diagnosing and treating neuroendocrine cancer

#7867
20110014197
2011-01-20

METHODS OF TREATING PRE-ECLAMPSIA OR ECLAMPSIA

#7868
20110014133
2011-01-20

Compositions and methods to treat asthma

#7869
20110014123
2011-01-20

RNA interference mediating small RNA molecules

#7870
20110010784
2011-01-13

Insulin-like gene of prawns and uses thereof

#7871
20110009473
2011-01-13

PTTG1 as a biomarker for cancer treatment

#7872
20110009468
2011-01-13

MIRNA, SIRNA AND USE THEREOF IN THERAPY

#7873
20110009467
2011-01-13

Methods to increase or decrease bone density

#7874
20110009281
2011-01-13

Methods for creating and identifying functional RNA interference elements

#7875
20110008885
2011-01-13

LINEAR DOUBLE-STRANDED RNA MOLECULE INTERFERING WITH DIFFERENT TARGET GENES

#7876
20110008882
2011-01-13

SPECIFIC GRP78 EXPRESSION-INHIBITION RNAi SEQUENCE, MEDICINE THEREOF AND METHOD THEREOF

#7877
20110008451
2011-01-13

Compositions and methods for controlled delivery of inhibitory ribonucleic acids

#7878
20110008370
2011-01-13

Use of FLJ25416 gene

#7879
20110008366
2011-01-13

Inhibition of versican with siRNA and other molecules

#7880
20110008350
2011-01-13

EXTRACELLULAR TARGETS FOR ALZHEIMER'S DISEASE

#7881
20110008320
2011-01-13

Further Use of Protein Kinase N Beta

#7882
20110003887
2011-01-06

Treating oncogenic Ras driven cancers

#7883
20110003882
2011-01-06

RNAi modulation of Aha and therapeutic uses thereof

#7884
20110003881
2011-01-06

Single stranded extended dicer substrate agents and methods for the specific inhibition of gene expression

#7885
20110003880
2011-01-06

Compositions and methods for inhibiting optic nerve damage

#7886
20110003714
2011-01-06

siRNA targeting beta secretase (BACE)

#7887
20110003713
2011-01-06

siRNA targeting apolipoprotein B (APOB)

#7888
20110003378
2011-01-06

Multiple promoter expression cassettes for simultaneous delivery of RNAi agents

#7889
20110003338
2011-01-06

ANTIBODIES WITH ENHANCED ADCC FUNCTION

#7890
20110003307
2011-01-06

Methods for producing interfering RNA molecules in mammalian cells and therapeutic uses for such molecules

#7891
20110003013
2011-01-06

METHOD OF INCREASING METABOLISM

#7892
20110002928
2011-01-06

Uses of Mammalian Cytokine; Related Reagents

#7893
20110002923
2011-01-06

Methods of inhibiting tumor growth using TTK antagonists

#7894
20100331394
2010-12-30

Methods and compositions for the treatment of eye disorders with increased intraocular pressure

#7895
20100331393
2010-12-30

Compositions and methods of sphingosine kinase inhibitors in radiation therapy of various cancers

#7896
20100331391
2010-12-30

ZAP-70 as predictor and modulator of effector function of T cells

#7897
20100331390
2010-12-30

EFFECTS OF APOLIPOPROTEIN B INHIBITION ON GENE EXPRESSION PROFILES IN ANIMALS

#7898
20100331389
2010-12-30

Compositions and methods for the specific inhibition of gene expression by dsRNA containing modified nucleotides

#7899
20100331234
2010-12-30

Aminoalcohol lipidoids and uses thereof

#7900
20100331214
2010-12-30

siRNA Targeting Survivin

#7901
20100330617
2010-12-30

Methods of producing a secreted protein

#7902
20100330583
2010-12-30

Compositions and methods for identification of PARP function, inhibitors, and activators

#7903
20100330155
2010-12-30

METHODS AND COMPOSITIONS FOR IMPROVED THERAPEUTIC EFFECTS WITH siRNA

#7904
20100330097
2010-12-30

PREDICTING AMD WITH SNPS WITHIN OR NEAR C2, FACTOR B, PLEKHA1, HTRA1, PRELP, OR LOC387715

#7905
20100330082
2010-12-30

NLRR-1 antagonists and uses thereof

#7906
20100330067
2010-12-30

Methods for suppressing Toll-like Receptor 4 (TLR4) function using TLR14 antagonists

#7907
20100330038
2010-12-30

Methods for expressing proteins in axons

#7908
20100325746
2010-12-23

Methods and sequences to suppress primate huntington gene expression in vivo

#7909
20100324278
2010-12-23

RNA synthesis-phosphoramidites for synthetic RNA in the reverse direction, and application in convenient introduction of ligands, chromophores and modifications of synthetic RNA at the 3′-end

#7910
20100324277
2010-12-23

Oligomeric compounds comprising 4′-thionucleosides for use in gene modulation

#7911
20100324154
2010-12-23

ASSESSING SUSCEPTIBILITY TO VASCULAR DISORDERS

#7912
20100324121
2010-12-23

METHODS AND COMPOSITIONS FOR THE SPECIFIC INHIBITION OF GENE EXPRESSION BY DOUBLE-STRANDED RNA

#7913
20100324120
2010-12-23

Lipid formulation

#7914
20100324117
2010-12-23

Hepatitis C dsRNA effector molecules, expression constructs, compositions, and methods of use

#7915
20100324116
2010-12-23

Fas/FasL or other death receptor targeted methods and compositions for killing tumor cells

#7916
20100324113
2010-12-23

Delivery Method

#7917
20100323922
2010-12-23

siRNA targeting TATA box binding protein (TBP)-associated factor (TAF1)

#7918
20100323018
2010-12-23

Branched DNA/RNA monomers and uses thereof

#7919
20100323001
2010-12-23

In vivo delivery of double stranded RNA to a target cell

#7920
20100322936
2010-12-23

LM-1 ANTIBODIES, FUNCTIONAL FRAGMENTS, LM-1 TARGET ANTIGEN, AND METHODS FOR MAKING AND USING SAME

#7921
20100322897
2010-12-23

CHARACTERIZATION OF IL-17F AND IL-17R INTERACTIONS

#7922
20100319074
2010-12-16

Multi-targeted RNAi therapeutics for scarless wound healing of skin

#7923
20100317840
2010-12-16

hnRNP K expression-inhibiting compound and siRNA sequence thereof

#7924
20100317839
2010-12-16

TP expression-inhibiting compound and siRNA sequence thereof

#7925
20100317721
2010-12-16

Compositions and methods for treating tumors, fibrosis, and pulmonary alveolar proteinosis

#7926
20100317717
2010-12-16

RNA interference mediated inhibition of platelet derived growth factor (PDGF) and platelet derived growth factor receptor (PDGFR) gene expression using short interfering nucleic acid (siNA)

#7927
20100317716
2010-12-16

RNA interference mediated inhibition of TNF and TNF receptor gene expression using short interfering nucleic acid (siNA)

#7928
20100317714
2010-12-16

COMPLEX MOLECULE INTERFERING THE EXPRESSION OF TARGET GENES AND ITS PREPARING METHODS

#7929
20100317713
2010-12-16

Micro-RNAS of the MIR-15 family modulate cardiomyocyte survival and cardiac repair

#7930
20100317610
2010-12-16

Methods and compositions for inducing deregulation of EPHA7 and ERK phosphorylation in human acute leukemias

#7931
20100317105
2010-12-16

Methods and compositions for controlling efficacy of RNA silencing

#7932
20100317049
2010-12-16

Stable cell lines and methods for evaluating gastrointestinal absorption of chemicals

#7933
20100316707
2010-12-16

Methods and compositions for enhancing delivery of double-stranded RNA or a double-stranded hybrid nucleic acid to regulate gene expression in mammalian cells

#7934
20100316703
2010-12-16

RNA interference mediating small RNA molecules

#7935
20100316699
2010-12-16

Compositions and methods for inhibiting viral replication

#7936
20100311958
2010-12-09

CARRIER, METHOD AND REAGENT FOR OBTAINING SMALL RNA

#7937
20100311819
2010-12-09

Method for down-regulating gene expression in fungi

#7938
20100311812
2010-12-09

RNA interference mediated inhibition of intercellular adhesion molecule (ICAM) gene expression using short interfering nucleic acid (siNA)

#7939
20100311810
2010-12-09

Modulation of diacylglycerol acyltransferase 2 expression

#7940
20100311808
2010-12-09

Methods, compositions and drug delivery systems for intraocular delivery of siRNA molecules

#7941
20100311807
2010-12-09

METHODS FOR IDENTIFYING DIABETES AND OBESITY THERAPEUTICS

#7942
20100311171
2010-12-09

Vectors for generating pluripotent stem cells and methods of producing pluripotent stem cells using the same

#7943
20100311082
2010-12-09

Stable cell lines and methods for evaluating gastrointestinal absorption of chemicals

#7944
20100310553
2010-12-09

Compositions and Methods for Controlling Hepatitis C Virus Infection

#7945
20100310521
2010-12-09

POLYNUCLEOTIDE SEQUENCE FOR THE INHIBITION OF PHOSPHOLAMBAN SYNTHESIS

#7946
20100310451
2010-12-09

ALTERED N-CADHERIN PROCESSING IN TUMOR CELLS BY FURIN AND PROPROTEIN CONVERTASE 5A (PC5A)

#7947
20100306879
2010-12-02

Polypeptides having cellobiohydrolase activity and polynucleotides encoding same

#7948
20100306869
2010-12-02

MODULATING PRODUCTION TRAITS IN AVIANS

#7949
20100305195
2010-12-02

MICRORNA MEDIATOR OF CARDIOMYOPATHY AND HEART FAILURE

#7950
20100305193
2010-12-02

RNAI-MEDIATED INHIBITION OF GREMLIN FOR TREATMENT OF IOP-RELATED CONDITIONS

#7951
20100305192
2010-12-02

Compositions and methods for short interfering nucleic acid inhibition of Na1.8

#7952
20100305191
2010-12-02

RNA INTERFERENCE MEDIATED INHIBITION OF ADENOSINE A1 RECEPTOR (ADORA1) GENE EXPRESSION USING SHORT INTERFERING RNA

#7953
20100305186
2010-12-02

METHODS FOR MEDIATING GENE SUPPRESSION

#7954
20100305034
2010-12-02

Growth factor isoform

#7955
20100303832
2010-12-02

GENES AND POLYMORPHISMS ASSOCIATED WITH AMD

#7956
20100303802
2010-12-02

Antibodies directed to mGluR7

#7957
20100303776
2010-12-02

Methods and compositions for regulated expression of multiple nucleic acids

#7958
20100299771
2010-11-25

MEANS AND METHODS FOR shRNA MEDIATED CONDITIONAL KNOCKDOWN OF GENES

#7959
20100299768
2010-11-25

Reversible siRNA-based silencing of mutant and endogenous wild-type huntingtin gene and its application for the treatment of Huntington's disease

#7960
20100298697
2010-11-25

METHOD AND DEVICES FOR IMPROVED EFFICIENCY OF RNA DELIVERY TO CELLS

#7961
20100298410
2010-11-25

MicromiRs

#7962
20100298409
2010-11-25

COMPOSITIONS COMPRISING STAT3 SIRNA AND METHODS OF USE THEREOF

#7963
20100298408
2010-11-25

Oligonucleotide Compositions with Enhanced Efficiency

#7964
20100298407
2010-11-25

COMPOSITIONS AND METHODS FEATURING MICRONAS FOR TREATING NEOPLASIA

#7965
20100298405
2010-11-25

Compositions and methods for inhibiting expression of Huntingtin gene

#7966
20100298404
2010-11-25

Translocation and mutant ROS kinase in human non-small cell lung carcinoma

#7967
20100298304
2010-11-25

Diagnosis of autism spectrum disorders and its treatment with an antagonist or inhibitor of the 5-HT2c receptor signaling pathway

#7968
20100297756
2010-11-25

MEANS FOR DELIVERY OF NUCLEIC ACIDS ACTIVE FOR GENE SILENCING USING SYNTHETIC POLYMERS

#7969
20100297149
2010-11-25

Compositions and methods comprising histidyl-tRNA synthetase splice variants having non-canonical biological activities

#7970
20100297109
2010-11-25

METHODS FOR INHIBITING FASCIN

#7971
20100297023
2010-11-25

Lipid

#7972
20100297015
2010-11-25

CANCER BIOMARKER AND USES THEREOF

#7973
20100297010
2010-11-25

TUMOR SUPPRESSOR GENE SCREENING USING RNA INTERFERENCE LIBRARIES AND METHOD OF TREATMENT

#7974
20100292456
2010-11-18

RNA interference mediating small RNA molecules

#7975
20100292455
2010-11-18

Modified iRNA agents

#7976
20100292308
2010-11-18

MicroRNA molecules

#7977
20100292305
2010-11-18

RNAi MODULATION OF HIF-1 AND THERAPUTIC USES THEREOF

#7978
20100292302
2010-11-18

INDUCTION OF APOPTOSIS AND INHIBITION OF CELL PROLIFERATION THROUGH MODULATION OF CARNITINE PALMITOYLTRANSFERASE 1C ACTIVITY

#7979
20100292301
2010-11-18

NOVEL SIRNA STRUCTURES

#7980
20100292300
2010-11-18

Compositions and methods for inhibiting or reversing fibrotic disorders

#7981
20100292299
2010-11-18

Nucleotide Motifs Providing Localization Elements and Methods of Use

#7982
20100292159
2010-11-18

Method of treatment or prophylaxis of inflammatory pain

#7983
20100291681
2010-11-18

Methods and compositions for selecting siRNA of improved functionality

#7984
20100291677
2010-11-18

REDUCER OF IMMUNOSUPPRESSION BY TUMOR CELL AND ANTITUMOR AGENT USING THE SAME

#7985
20100291673
2010-11-18

Alternative export pathways for vector expressed RNA interference

#7986
20100291624
2010-11-18

Compositions and methods for improved glycoprotein sialylation

#7987
20100291194
2010-11-18

Compositions and methods for inhibiting expression of a mutant gene

#7988
20100291091
2010-11-18

CANCER ASSOCIATED GENE LY6K

#7989
20100291077
2010-11-18

Methods and compositions for modulating ErbB2 activity

#7990
20100286378
2010-11-11

Composition of Asymmetric RNA Duplex As MicroRNA Mimetic or Inhibitor

#7991
20100286246
2010-11-11

Identification of novel genes coding for small temporal RNAS

#7992
20100286245
2010-11-11

Identification of novel genes coding for small temporal RNAs

#7993
20100286244
2010-11-11

RNAi mediated knockdown of NuMA for cancer therapy

#7994
20100286243
2010-11-11

MIG-7 AS A SPECIFIC ANTICANCER TARGET

#7995
20100286242
2010-11-11

siRNA-mediated gene silencing of synuclein

#7996
20100286241
2010-11-11

COMPOSITIONS COMPRISING K-RAS SIRNA AND METHODS OF USE

#7997
20100286238
2010-11-11

SUPPRESSION OF VIRUSES INVOLVED IN RESPIRATORY INFECTION OR DISEASE

#7998
20100286237
2010-11-11

Pro-angiogenic genes in ovarian tumor endothelial cell isolates

#7999
20100286233
2010-11-11

PERIPHERAL AND NEURAL INFLAMMATORY CROSSTALK

#8000
20100286230
2010-11-11

Modulation of TRPV expression levels

#8001
20100286229
2010-11-11

Modulation of Androgen Receptor for Treatment of Prostate Cancer

#8002
20100286228
2010-11-11

Method of inhibiting intimal hyperplasia

#8003
20100285484
2010-11-11

Apoptosis inducing positive control for expression modulation experiments

#8004
20100285107
2010-11-11

Short nucleic acid molecule-mediated modulation of Aurora B kinase expression and combinations for use in anticancer therapy

#8005
20100285031
2010-11-11

Hox Compositions and Methods

#8006
20100285026
2010-11-11

Phosphorylation of histone H3 at threonine 11—a novel epigenetic mark for transcriptional regulation

#8007
20100285024
2010-11-11

Vaccine compositions and methods for treatment of mucormycosis and other fungal diseases

#8008
20100285002
2010-11-11

TREATMENT OR PREVENTION OF INFLAMMATION BY TARGETING CYCLIN D1

#8009
20100284968
2010-11-11

Use of PS20/WFDC1 and Interferons to Diagnose, Monitor and Treat Viral Diseases

#8010
20100284907
2010-11-11

Treatment of tumors by ablating bone marrow-derived endothelial progenitor cells

#8011
20100281548
2010-11-04

Animal models for demyelination disorders

#8012
20100280102
2010-11-04

DOUBLE-STRANDED RIBONUCLEIC ACID WITH INCREASED EFFECTIVENESS IN AN ORGANISM

#8013
20100280101
2010-11-04

Method of inhibiting cancer cell proliferation, proliferation inhibitor and screening method

#8014
20100280099
2010-11-04

Combination treatment for the treatment of hepatitis C virus infection

#8015
20100280098
2010-11-04

RECEPTOR TARGETED OLIGONUCLEOTIDES

#8016
20100280097
2010-11-04

COMPOSITIONS COMPRISING HIF-1 ALPHA SIRNA AND METHODS OF USE THEREOF

#8017
20100280096
2010-11-04

Treatment of influenza

#8018
20100280095
2010-11-04

Therapeutic agent for wounds and screening method for the same

#8019
20100279921
2010-11-04

IMPAIRED WOUND HEALING COMPOSITIONS AND TREATMENTS

#8020
20100279919
2010-11-04

COMPOSITIONS COMPRISING HUMAN INTEGRIN-LINKED KINASE-SIRNA AND METHODS OF USE THEREOF

#8021
20100279896
2010-11-04

siRNA targeting interleukin-1 receptor-associated kinase 4(IRAK4)

#8022
20100279415
2010-11-04

Lepidopteran insect N-acetylglucosaminidase genes and their use in glycoengineering

#8023
20100279408
2010-11-04

POLYMERIC SHORT INTERFERING RNA CONJUGATES

#8024
20100279291
2010-11-04

Gene silencing of the brother of the regulator of imprinted sites (BORIS)

#8025
20100278841
2010-11-04

Down-regulation of mortalin by siRNA

#8026
20100278837
2010-11-04

Compositions And Methods For Reducing Cancer And Inflammation

#8027
20100278829
2010-11-04

DUAL INHIBITION OF IMMUNOPHILIN/CYCLOPHILIN FAMILY MEMBERS AND EMMPRIN IMMUNOGLOBULIN RECEPTOR SUPERFAMILY MEMBERS

#8028
20100278825
2010-11-04

Mammalian receptor proteins DCRS5; method of treatment

#8029
20100278809
2010-11-04

Inhibitors of MRP4 for the treatment of vascular disorders

#8030
20100278797
2010-11-04

Pharmaceutical composition and method for regulating abnormal cellular proliferation

#8031
20100278789
2010-11-04

METHODS OF GENERATING EXPANDED AND RE-DIFFERENTIATED ADULT ISLET BETA CELLS CAPABLE OF PRODUCING INSULIN

#8032
20100273998
2010-10-28

METHODS AND COMPOSITIONS FOR MODULATING TISSUE FACTOR

#8033
20100273863
2010-10-28

Modulation of gene expression using oligomers that target gene regions downstream of 3′ untranslated regions

#8034
20100273859
2010-10-28

TREATMENT AND PREVENTION OF HIV INFECTION

#8035
20100273858
2010-10-28

COMPOSITIONS COMPRISING STAT5 SIRNA AND METHODS OF USE THEREOF

#8036
20100273857
2010-10-28

Suppression of SCN9A gene expression and/or function for the treatment of pain

#8037
20100273855
2010-10-28

COMPOSITIONS AND METHODS OF TREATING CANCER

#8038
20100273854
2010-10-28

COMPOSITIONS AND METHODS FOR INHIBITING NADPH OXIDASE EXPRESSION

#8039
20100273707
2010-10-28

Methods of inhibiting tumor cell aggressiveness using the microenvironment of human embryonic stem cells

#8040
20100273255
2010-10-28

Human microRNAs and methods for inhibiting same

#8041
20100273220
2010-10-28

INNATE IMMUNE SUPPRESSION ENABLES REPEATED DELIVERY OF LONG RNA MOLECULES

#8042
20100272813
2010-10-28

NANOPARTICLE-MEDIATED TREATMENT FOR INFLAMMATORY DISEASES

#8043
20100272805
2010-10-28

HYDROGELS FOR COMBINATORIAL DELIVERY OF IMMUNE-MODULATING BIOMOLECULES

#8044
20100272722
2010-10-28

Therapeutic uses of inhibitors of RTP801

#8045
20100272712
2010-10-28

JNK3 as a target for the treatment of angiogenesis-related diseases

#8046
20100267941
2010-10-21

iRNA agents with biocleavable tethers

#8047
20100267813
2010-10-21

Method for inhibiting the activity of mir-155

#8048
20100267811
2010-10-21

RNAi-RELATED INHIBITION OF TNFa SIGNALING PATHWAY FOR TREATMENT OF OCULAR ANGIOGENESIS

#8049
20100267810
2010-10-21

METHODS AND COMPOSITIONS FOR TREATING NEUROLOGICAL DISEASE

#8050
20100267809
2010-10-21

Double stranded nucleic acid targeting low copy promoter-specific RNA

#8051
20100267806
2010-10-21

LIPID FORMULATED COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF Eg5 AND VEGF GENES

#8052
20100267805
2010-10-21

Targeting opposite strand replication intermediates of single-stranded viruses by RNAI

#8053
20100267802
2010-10-21

DELIVERY METHOD

#8054
20100267587
2010-10-21

siRNA targeting cyclin dependent kinase 11 (CDK11)

#8055
20100267586
2010-10-21

siRNA targeting KRAS

#8056
20100267149
2010-10-21

Methods of determining potency of chemically-synthesized oligonucleotides

#8057
20100267146
2010-10-21

Method for expression of small antiviral RNA molecules with reduced cytotoxicity within a cell

#8058
20100267110
2010-10-21

Laccases, nucleic acids encoding them and methods for making and using them

#8059
20100267072
2010-10-21

Formation/elongation of axon by inhibiting the expression or function of Singar and application to nerve regeneration

#8060
20100266680
2010-10-21

Treatment of cancer using TLR3 agonists

#8061
20100266579
2010-10-21

TREATMENT OF INFLAMMATORY DISEASES

#8062
20100266577
2010-10-21

Method of Cancer Treatment with Antagonists of FAS Inhibitors

#8063
20100266574
2010-10-21

Oligoribonucleotides and Methods of Use Thereof for Treatment of Fibrotic Conditions and Other Diseases

#8064
20100266503
2010-10-21

Breast Cancer Methods, Medicaments and Agents

#8065
20100263066
2010-10-14

INERT DNA SEQUENCES FOR EFFICIENT VIRAL PACKAGING AND METHODS OF USE

#8066
20100261776
2010-10-14

BRUTON'S TYROSINE KINASE AS ANTI-CANCER DRUG TARGET

#8067
20100261175
2010-10-14

USE OF SHORT OLIGONUCLEOTIDES FOR REAGENT REDUNDANCY EXPERIMENTS IN RNA FUNCTIONAL ANALYSIS

#8068
20100260850
2010-10-14

Controlled Release Devices and Methods for Delivery of Nucleic Acids

#8069
20100260808
2010-10-14

Method for increasing immunoreactivity

#8070
20100260730
2010-10-14

SHIP-deficiency to increase megakaryocyte progenitor production

#8071
20100257634
2010-10-07

BIOASSAY FOR GENE SILENCING CONSTRUCTS

#8072
20100257617
2010-10-07

Transgenic animals comprising gene fusions

#8073
20100256219
2010-10-07

Small interfering DNA (siDNA) oligonucleotides as an antiviral agent against Herpes virus infections

#8074
20100256218
2010-10-07

RNAi modulation of MLL-AF4 and uses thereof

#8075
20100256217
2010-10-07

ANTIVIRAL INHIBITION OF CASEIN KINASE II

#8076
20100255117
2010-10-07

METHODS AND COMPOSITIONS FOR THE TREATMENT OF CANCER

#8077
20100255112
2010-10-07

Efficient Nuclear Delivery of Antisense Oligonucleotides or siRNA In Vitro and In Vivo by Nano-Transforming Polymersomes

#8078
20100255023
2010-10-07

Dendritic cell vaccine compositions and uses of same

#8079
20100254998
2010-10-07

METHOD FOR PROLONGING LONGEVITY

#8080
20100254976
2010-10-07

Use of protease nexin 1 inhibitors to reduce metastasis

#8081
20100254945
2010-10-07

Rnai Therapeutic for Respiratory Virus Infection

#8082
20100249216
2010-09-30

Method for the production of a cell and/or tissue and/or disease phase specific medicament

#8083
20100249215
2010-09-30

Oligomeric compounds and compositions for use in modulation of pri-miRNAs

#8084
20100249214
2010-09-30

MULTIPLEX DICER SUBSTRATE RNA INTERFERENCE MOLECULES HAVING JOINING SEQUENCES

#8085
20100249052
2010-09-30

DSRNA COMPOSITIONS AND METHODS FOR TREATING HPV INFECTIONS

#8086
20100248990
2010-09-30

siRNA targeting ribonucleotide reductase M2 polypeptide (RRM2 or RNR-R2)

#8087
20100247530
2010-09-30

COMPOSITIONS AND METHODS FOR PREVENTING AND TREATING PRESBYCUSIS

#8088
20100247527
2010-09-30

Method for the treatment of rheumatoid arthritis using a TLR2 antagonistic antibody

#8089
20100240881
2010-09-23

Therapeutic compositions

#8090
20100240738
2010-09-23

Antisense modulation of kinesin-like 1 expression

#8091
20100240734
2010-09-23

METHODS AND COMPOSITIONS FOR THE SPECIFIC INHIBITION OF GENE EXPRESSION BY DOUBLE-STRANDED RNA

#8092
20100240732
2010-09-23

APTAMER-TARGETED SIRNA TO PREVENT ATTENUATION OR SUPPRESSION OF A T CELL FUNCTION

#8093
20100240731
2010-09-23

LIPOPEPTIDES FOR DELIVERY OF NUCLEIC ACIDS

#8094
20100240730
2010-09-23

RNA Interference Mediated Inhibition of Gene Expression Using Chemically Modified Short Interfering Nucleic Acid (siNA)

#8095
20100240673
2010-09-23

EML4-ALK fusion gene

#8096
20100240665
2010-09-23

Biological markers predictive of anti-cancer response to insulin-like growth factor-1 receptor kinase inhibitors

#8097
20100240554
2010-09-23

SiRNA targeting glucagon receptor (GCGR)

#8098
20100239581
2010-09-23

Detection of CXADR protein for diagnosis of kidney cancer

#8099
20100239566
2010-09-23

Enigma-Mdm2 interaction and uses thereof

#8100
20100239565
2010-09-23

Methods of treatment of skin ulcers